These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Tamoxifen prevention claim will not be allowed in USA. Ault A Lancet; 1998 Sep; 352(9131):883. PubMed ID: 9742990 [No Abstract] [Full Text] [Related]
6. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer. Cohen MH; Johnson JR; Li N; Chen G; Pazdur R Clin Cancer Res; 2002 Mar; 8(3):665-9. PubMed ID: 11895893 [TBL] [Abstract][Full Text] [Related]
8. National Surgical Adjuvant Breast and Bowel Project breast cancer prevention trial: a reflective commentary. Fisher B J Clin Oncol; 1999 May; 17(5):1632-9. PubMed ID: 10334553 [No Abstract] [Full Text] [Related]
9. Breast cancer prevention trials 'can re-start'. Gavaghan H Nature; 1994 Jun; 369(6481):515. PubMed ID: 8202147 [No Abstract] [Full Text] [Related]
11. Chemoprevention of breast cancer. Dalton RR; Kallab AM South Med J; 2001 Jan; 94(1):7-15. PubMed ID: 11213947 [TBL] [Abstract][Full Text] [Related]
12. Breast surgery in the 'Arimidex, Tamoxifen Alone or in Combination' (ATAC) trial: American women are more likely than women from the United Kingdom to undergo mastectomy. Locker GY; Sainsbury JR; Cuzick J; Cancer; 2004 Aug; 101(4):735-40. PubMed ID: 15305403 [TBL] [Abstract][Full Text] [Related]
13. [Is low-dose tamoxifen an effective therapy for breast carcinoma in situ?]. Ivanova OA; Zhil'tsova EK; Barash NIu; Ivanov VG; Ermachenkova AM Vopr Onkol; 2011; 57(5):601-3. PubMed ID: 22238929 [No Abstract] [Full Text] [Related]
14. Letrozole in the extended adjuvant treatment of postmenopausal women with history of early-stage breast cancer who have completed 5 years of adjuvant tamoxifen. Mann BS; Johnson JR; Kelly R; Sridhara R; Williams G; Pazdur R Clin Cancer Res; 2005 Aug; 11(16):5671-7. PubMed ID: 16115902 [TBL] [Abstract][Full Text] [Related]
15. Searching for the next tamoxifen. Hobson K US News World Rep; 2003 Oct; 135(13):44. PubMed ID: 14584460 [No Abstract] [Full Text] [Related]
16. Tamoxifen prophylaxis in breast cancer. Love RR Oncology (Williston Park); 1992 Jul; 6(7):33-8; discussion 38-40, 43. PubMed ID: 1386239 [TBL] [Abstract][Full Text] [Related]
17. Drug approval summaries: arsenic trioxide, tamoxifen citrate, anastrazole, paclitaxel, bexarotene. Cohen MH; Hirschfeld S; Flamm Honig S; Ibrahim A; Johnson JR; O'Leary JJ; White RM; Williams GA; Pazdur R Oncologist; 2001; 6(1):4-11. PubMed ID: 11161223 [TBL] [Abstract][Full Text] [Related]
18. Advanced age and adjuvant tamoxifen prescription in early-stage breast carcinoma patients. Blackman SB; Lash TL; Fink AK; Ganz PA; Silliman RA Cancer; 2002 Dec; 95(12):2465-72. PubMed ID: 12467058 [TBL] [Abstract][Full Text] [Related]
19. Effect of mifepristone approval on research remains to be seen. Vastag B J Natl Cancer Inst; 2000 Dec; 92(24):1970-1. PubMed ID: 11121453 [No Abstract] [Full Text] [Related]
20. The effect of SERMs on the endometrium. Goldstein SR Ann N Y Acad Sci; 2001 Dec; 949():237-42. PubMed ID: 11795358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]